Chartwell Investment Partners’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-39,783
Closed -$3.51M 435
2022
Q3
$3.51M Sell
39,783
-920
-2% -$95.1K 0.15% 216
2022
Q2
$4.1M Buy
40,703
+520
+1% +$65.1K 0.16% 199
2022
Q1
$5.83M Sell
40,183
-2,913
-7% -$403K 0.19% 180
2021
Q4
$5.59M Sell
43,096
-2,144
-5% -$276K 0.16% 200
2021
Q3
$6.26M Sell
45,240
-967
-2% -$146K 0.19% 186
2021
Q2
$6.77M Sell
46,207
-6,271
-12% -$948K 0.2% 177
2021
Q1
$7M Sell
52,478
-21,871
-29% -$2.9M 0.21% 168
2020
Q4
$10.2M Sell
74,349
-2,276
-3% -$283K 0.33% 122
2020
Q3
$8.2M Buy
76,625
+1,559
+2% +$167K 0.3% 134
2020
Q2
$6.97M Sell
75,066
-970
-1% -$97K 0.27% 149
2020
Q1
$7.53M Sell
76,036
-12,005
-14% -$1.52M 0.35% 112
2019
Q4
$12.6M Sell
88,041
-4,516
-5% -$644K 0.42% 99
2019
Q3
$13.8M Sell
92,557
-5,583
-6% -$802K 0.46% 68
2019
Q2
$12.8M Buy
+98,140
New +$12.4M 0.42% 89

Other funds holding UHS

Chartwell Investment Partners's UHS Position: Q4 2022 in Review

Chartwell Investment Partners sold out of Universal Health Services (UHS) in Q4 2022, closing a stake of 39,783 shares — an estimated $3.51M sold.

Chartwell Investment Partners first reported a position in UHS in Q2 2019 and held it in 14 quarters. The position peaked at $13.8M in Q3 2019. 435 funds tracked by Wall St. Rank hold UHS as of Q4 2022.

  • Chartwell Investment Partners reported no remaining Universal Health Services position as of Q4 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 39,783 Universal Health Services shares in Q4 2022, an estimated $3.51M.
  • Chartwell Investment Partners first reported a position in Universal Health Services in Q2 2019 and held it in 14 quarters.
  • Chartwell Investment Partners's Universal Health Services position peaked at $13.8M in Q3 2019.
  • 435 funds tracked by Wall St. Rank held Universal Health Services as of Q4 2022.

Based on Chartwell Investment Partners's 13F filing for Q4 2022, filed 16 Feb 2023.